International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

A narrative Review about Common Complications of Type 1 Diabetes

Article Information

Volume / Issue7 / 1 (January-March 2026)
Pages165-170
AccessOpen Access

Publication Timeline

  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Type 1 diabetes (T1D), or insulin-dependent diabetes, is a persistent autoimmune problem and a type of diabetes in which insulin levels are low on account to the demolition of pancreatic beta cells. It is one of the most common health problems of our time. Although blood glucose levels can be controlled, there is a risk of complications that can have a negative impact on daily life. This review aims to list and summarize the common complications of this disease that occur after infection, as they require continuous monitoring and fruitful management strategies. Health care providers should have a comprehensive and organized program that includes ongoing and organized testing of patients, educational support, psychological support for the patient, and improving glucose control as a basic requirement for maintaining general health and reducing complications.

References

  1. Kahanovitz L, Sluss PM, Russell SJ. Type 1 diabetes – a clinical perspective. Point Care. 2017;16(1):37-40. doi:10.1097/POC.0000000000000125. [Google Scholar][Crossref]
  2. Chiang JL, Kirkman MS, Laffel LMB, Peters AL; Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034-2054. doi:10.2337/dc14-1140. [Google Scholar][Crossref]
  3. Boscari F, Avogaro A. Current treatment options and challenges in patients with type 1 diabetes: pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord. 2021;22(2):217-240. doi:10.1007/s11154-021-09635-3. [Google Scholar][Crossref]
  4. Chamine I, Hwang J, Valenzuela S, Marino M, Larson AE, Georgescu J, et al. Acute and chronic diabetes-related complications among patients with diabetes receiving care in community health centers. Diabetes Care. 2022;45(10):e141-e143. doi:10.2337/dc22-0420. [Google Scholar][Crossref]
  5. Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008;93(5):1541-1552. doi:10.1210/jc.2007-2577. [Google Scholar][Crossref]
  6. El-Remessy AB. Diabetic ketoacidosis management: updates and challenges for specific patient population. Endocrines. 2022;3:801 -812. doi:10.3390/endocrines3040066. [Google Scholar][Crossref]
  7. Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024;47(8):1257-1275. doi:10.2337/dci24-0032. [Google Scholar][Crossref]
  8. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335 -1343. doi:10.2337/dc09-9032. [Google Scholar][Crossref]
  9. Li S, Xiao X, Zhang X. Hydration status in older adults: current knowledge and future challenges. Nutrients. 2023;15(11):2609. doi:10.3390/nu15112609. [Google Scholar][Crossref]
  10. Hassan EM, Mushtaq H, Mahmoud EE, Chhibber S, Saleem S, Issa A, et al. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state. World J Clin Cases. 2022;10(32):11702 -11711. doi:10.12998/wjcc.v10.i32.11702. [Google Scholar][Crossref]
  11. Khin PP, Lee JH, Jun HS. Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm. 2023;21:1721727X231154152. doi:10.1177/1721727X231154152. [Google Scholar][Crossref]
  12. Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin. 2001;19(3):489-505. doi:10.1016/S0733-8651(05)70231-9. [Google Scholar][Crossref]
  13. Lowe RN, Williams B, Claus LW. Diabetes: how to International Journal of Medical and All Body Health Research www.allmedicaljournal.com manage patients experiencing hypoglycaemia. Drugs Context. 2022;11:2021-9-11. doi:10.7573/dic.2021-9-11. [Google Scholar][Crossref]
  14. Martín-Timón I, Del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes. 2015;6(7):912-926. doi:10.4239/wjd.v6.i7.912. [Google Scholar][Crossref]
  15. Awoniyi O, Rehman R, Dagogo-Jack S. Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention. Curr Diab Rep. 2013;13:669-678. doi:10.1007/s11892-013-0411-y. [Google Scholar][Crossref]
  16. Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME; DCCT/EDIC Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the DCCT/EDIC cohort. Diabetes Care. 2013;36(10):3131-3138. doi:10.2337/dc12-2109. [Google Scholar][Crossref]
  17. Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, et al. Risk factors for cardiovascular disease in adults with type 1 diabetes: findings from the T1D Exchange Registry. J Clin Endocrinol Metab. 2020;105(5):e2032-e2038. doi:10.1210/clinem/dgaa015. [Google Scholar][Crossref]
  18. Higashi Y. Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease. Antioxidants (Basel). 2022;11(10):1958. doi:10.3390/antiox11101958. [Google Scholar][Crossref]
  19. Ahuja A, Agrawal S, Acharya S, Reddy V, Batra N. Strategies for cardiovascular disease prevention in type 1 diabetes: a comprehensive review. Cureus. 2024;16(8):e66420. doi:10.7759/cureus.66420. [Google Scholar][Crossref]
  20. Vergès B. Cardiovascular disease in type 1 diabetes, an underestimated danger: epidemiological and pathophysiological data. Atherosclerosis. 2024;394:117158. doi:10.1016/j.atherosclerosis.2023.06.005. [Google Scholar][Crossref]
  21. Bjornstad P, Cherney D, Maahs DM. Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes. 2014;21(4):279-286. doi:10.1097/MED.0000000000000074. [Google Scholar][Crossref]
  22. Shilpasree AS, Patil VS, Revanasiddappa M, Patil VP, Ireshnavar D. Renal dysfunction in prediabetes: confirmed by glomerular hyperfiltration and albuminuria. J Lab Physicians. 2021;13(3):257-262. doi:10.1055/s-0041-1731107. [Google Scholar][Crossref]
  23. Opsahl JA, Abraham PA, Keane WF. Angiotensin-converting enzyme inhibitors in chronic renal failure. Drugs. 1990;39 Suppl 2:23-32. doi:10.2165/00003495-199000392-00006. [Google Scholar][Crossref]
  24. Popovic DS, Patoulias D, Gnudi L, Mantzoros CS. Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes. Metabolism. 2024;151:155763. doi:10.1016/j.metabol.2023.155763. [Google Scholar][Crossref]
  25. Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. EPMA J. 2023;14(1):21-42. doi:10.1007/s13167-023-00314-8. [Google Scholar][Crossref]
  26. Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int. 2010;107(5):75-83. doi:10.3238/arztebl.2010.0075. [Google Scholar][Crossref]
  27. Pandya M, Banait S, Daigavane S. Insights into visual rehabilitation: pan-retinal photocoagulation for proliferative diabetic retinopathy. Cureus. 2024;16(2):e54273. doi:10.7759/cureus.54273. [Google Scholar][Crossref]
  28. Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol. 2022;13:1055087. doi:10.3389/fimmu.2022.1055087. [Google Scholar][Crossref]
  29. Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365(9466):1259-1270. doi:10.1016/S0140-6736(05)74815-7. [Google Scholar][Crossref]
  30. Spagnoli C, Pisani F, Di Mario F, Leandro G, Gaiani F, De' Angelis GL, et al. Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association. Acta Biomed. 2018;89(9 Suppl):22-32. doi:10.23750/abmv89i9-S.7956. [Google Scholar][Crossref]
  31. Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther. 2012;3(1):4. doi:10.1007/s13300-012-0004-9. [Google Scholar][Crossref]
  32. Muthulingam JA, Brock C, Hansen TM, Drewes AM, Brock B, Frøkjær JB. Disrupted white matter integrity in the brain of type 1 diabetes is associated with peripheral neuropathy and abnormal brain metabolites. J Diabetes Complications. 2022;36(9):108267. doi:10.1016/j.jdiacomp.2022.108267. [Google Scholar][Crossref]
  33. Sugandh F, Chandio M, Raveena F, Kumar L, Karishma F, Khuwaja S, et al. Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus. 2023;15(8):e43697. doi:10.7759/cureus.43697. [Google Scholar][Crossref]
  34. de Wit M, Gajewska KA, Goethals ER, McDarby V, Zhao X, Hapunda G, et al. ISPAD clinical practice consensus guidelines 2022: psychological care of children, adolescents and young adults with diabetes. Pediatr Diabetes. 2022;23(8):1373 -1389. doi:10.1111/pedi.13428. [Google Scholar][Crossref]
  35. Russo K. Assessment and treatment of adolescents with chronic medical conditions. J Health Serv Psychol. 2022;48(2):69-78. doi:10.1007/s42843-022-00059-4. [Google Scholar][Crossref]
  36. Joo JH, Bone L, Forte J, Kirley E, Lynch T, Aboumatar H. The benefits and challenges of established peer support programmes for patients, informal caregivers, and healthcare providers. Fam Pract. 2022;39(5):903-912. doi:10.1093/fampra/cmac004. [Google Scholar][Crossref]
  37. Bombaci B, Torre A, Longo A, Pecoraro M, Papa M, Sorrenti L, et al. Psychological and clinical challenges in the management of type 1 diabetes during adolescence: a narrative review. Children (Basel). 2024;11(9):1085. doi:10.3390/children11091085. [Google Scholar][Crossref]

How to Cite

Hamza, A. T. (2026). A narrative Review about Common Complications of Type 1 Diabetes. International Journal of Medical and All Body Health Research, 7(1), 165-170. https://doi.org/10.54660/IJMBHR.2026.7.1.165-170

Hamza, Alaa Talib. "A narrative Review about Common Complications of Type 1 Diabetes." International Journal of Medical and All Body Health Research, vol. 7, no. 1, 2026, pp. 165-170. https://doi.org/10.54660/IJMBHR.2026.7.1.165-170.

Hamza, A. T. (2026) 'A narrative Review about Common Complications of Type 1 Diabetes', International Journal of Medical and All Body Health Research, 7(1), pp. 165-170. doi: 10.54660/IJMBHR.2026.7.1.165-170.

Hamza AT. A narrative Review about Common Complications of Type 1 Diabetes. International Journal of Medical and All Body Health Research. 2026;7(1):165-170. doi:10.54660/IJMBHR.2026.7.1.165-170

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.